XAGE (Longevity Health Holdings) Total Inventories : $0.11 Mil (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Longevity Health Holdings Total Inventories?

Longevity Health Holdings's total inventories for the quarter that ended in Dec. 2024 was $0.11 Mil. Longevity Health Holdings's average total inventories from the quarter that ended in Sep. 2024 to the quarter that ended in Dec. 2024 was $0.10 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Longevity Health Holdings's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was $-0.21.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Longevity Health Holdings's Days Inventory for the three months ended in Dec. 2024 was 9,444.37.

Inventory Turnover measures how fast the company turns over its inventory within a year. Longevity Health Holdings's Inventory Turnover for the quarter that ended in Dec. 2024 was 0.01.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Longevity Health Holdings's Inventory-to-Revenue for the quarter that ended in Dec. 2024 was 6.09.

Longevity Health Holdings Total Inventories Historical Data

The historical data trend for Longevity Health Holdings's Total Inventories can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longevity Health Holdings Total Inventories Chart

Longevity Health Holdings Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Total Inventories

0.11

Longevity Health Holdings Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Inventories	Get a 7-Day Free Trial							-	-	0.11	0.10	0.11

Longevity Health Holdings Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Longevity Health Holdings (NAS:XAGE) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Longevity Health Holdings's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is

	Net-Net Working Capital Per Share (Q: Dec. 2024 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(0.157	+	0.75 * 0.004	+	0.5 * 0.109	-	6.187
-	0	-	0)	/	28.971
=	-0.21

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Longevity Health Holdings's Days Inventory for the three months ended in Dec. 2024 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2024 )	/	Cost of Goods Sold (Q: Dec. 2024 )	*	Days in Period
	=	0.1035	/	0.001	*	365 / 4
	=	9,444.37

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Longevity Health Holdings's Inventory Turnover for the quarter that ended in Dec. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2024 )	/	Average Total Inventories (Q: Dec. 2024 )
	=	0.001	/	0.1035
	=	0.01

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Longevity Health Holdings's Inventory to Revenue for the quarter that ended in Dec. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	0.1035	/	0.017
	=	6.09

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Longevity Health Holdings Total Inventories Related Terms

Thank you for viewing the detailed overview of Longevity Health Holdings's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Longevity Health Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Longevity Health Holdings Inc (NAS:XAGE) » Definitions » Total Inventories

Comparable Companies

Traded in Other Exchanges

N/A

Address

2403 Sidney Street, Suite 300, Pittsburgh, PA, USA, 15203

Website

https://www.carmellcorp.com

Longevity Health Holdings Inc is a United States based bio-aesthetics company that utilizes the Secretome to support skin and hair health.

Executives

Richard A Upton	director	12 MIDDLE STREET, AMHERST NH 03031
Kathryn Gregory	director	305 THAYER POND ROAD, WILTON CT 06897
Patrick A Sturgeon	officer: CFO and Secretary	600 LEXINGTON AVENUE 33 FLOOR, NEW YORK NY 10022
David W Anderson	director	519 LYNMERE ROAD, BRYN MAWR PA 19010
Rajiv Shukla	director, 10 percent owner, officer: Chief Executive Officer	EMERALD VIEW SUITE 400, 2054 VISTA PARKWAY, WEST PALM BEACH FL 33411
Randolph W Hubbell	director, officer: President and CEO	C/O CARMELL THERAPEUTICS CORPORATION, 2403 SIDNEY STREET, SUITE 300, PITTSBURGH PA 15203
William R Newlin	director	C/O CARMELL THERAPEUTICS CORPORATION, 2403 SIDNEY STREET, SUITE 300, PITTSBURGH PA 15203
Steven Bariahtaris	director	C/O CARMELL THERAPEUTICS CORPORATION, 2403 SIDNEY STREET, SUITE 300, PITTSBURGH PA 15203
Jaime Garza	director	C/O CARMELL THERAPEUTICS CORPORATION, 2403 SIDNEY STREET, SUITE 300, PITTSBURGH PA 15203
Janet Vargo	officer: VP Clinical Services	C/O CARMELL THERAPEUTICS CORPORATION, 2403 SIDNEY STREET, SUITE 300, PITTSBURGH PA 15203
Donna Godward	officer: Chief Quality Officer	C/O CARMELL THERAPEUTICS CORPORATION, 2403 SIDNEY STREET, SUITE 300, PITTSBURGH PA 15203
James C Hart	officer: Chief Medical Officer	C/O CARMELL THERAPEUTICS CORPORATION, 2403 SIDNEY STREET, SUITE 300, PITTSBURGH PA 15203
William Woodward	director	ANTHEM VENTURE PARTNERS, 225 ARIZONA AVENUE, SUITE 200, SANTA MONICA CA 90401
Darlene T Deremer	director	200 CENTRAL AVENUE, SUITE 1850, ST. PETERSBURG FL 33701
Ahac Sponsor Iii Llc	10 percent owner	1177 AVENUE OF THE AMERICAS, 5TH FLOOR, NEW YORK NY 10036